ConductScience.org, home

Paper32389751

Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.

Wei H and 3 others. Neuropharmacology, 2020. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration. Papers, record 32389751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32389751

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.
PubMed
Journal
Neuropharmacology
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2024-09-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei HHuimei
2Zhang TTing
3Zhan CGChang-Guo
4Zheng FFang

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Analgesics, OpioidMajor topic
Cocaine-Related DisordersMajor topic
IndolesMajor topic
Spiro CompoundsMajor topic
Animals
Conditioning, Operant
Dose-Response Relationship, Drug
Heroin
Male
Rats
Rats, Sprague-Dawley
Reinforcement Schedule
Self Administration

Source PubMed

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UH2 DA041115NIDA NIH HHSUnited StatesUH2DA041115PubMed and NIHNIH RePORTER
R01 DA035552NIDA NIH HHSUnited StatesR01DA035552PubMed and NIHNIH RePORTER
R01 DA025100NIDA NIH HHSUnited StatesR01DA025100PubMed and NIHNIH RePORTER
R01 DA032910NIDA NIH HHSUnited StatesR01DA032910PubMed and NIHNIH RePORTER
UH3 DA041115NIDA NIH HHSUnited StatesUH2DA041115PubMed and NIHNIH RePORTER
U18 DA052319NIDA NIH HHSUnited StatesU18DA052319PubMedNIH RePORTER
U01 DA051079NIDA NIH HHSUnited StatesU01DA051079PubMedNIH RePORTER
R01 DA013930NIDA NIH HHSUnited StatesR01DA013930PubMed and NIHNIH RePORTER
UH3DA041115NIHNIH RePORTER

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,161,378Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications.Future Med Chem2009https://conductscience.org/library/papers/20161378PubMed
231,499,241In vivo characterization of toxicity of norcocaethylene and norcocaine identified as the most toxic cocaine metabolites in male mice.Drug Alcohol Depend2019https://conductscience.org/library/papers/31499241PubMed
314,624,331Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.Psychopharmacology (Berl)2004https://conductscience.org/library/papers/14624331PubMed
531,152,783Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks.J Pain Symptom Manage2019https://conductscience.org/library/papers/31152783PubMed
629,180,970Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.Front Psychiatry2017https://conductscience.org/library/papers/29180970PubMed
730,080,993Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine.Chem Biol Interact2018https://conductscience.org/library/papers/30080993PubMed
822,300,091Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?Future Med Chem2012https://conductscience.org/library/papers/22300091PubMed
921,371,010Predictive validity of behavioural animal models for chronic pain.Br J Pharmacol2011https://conductscience.org/library/papers/21371010PubMed
1019,474,215Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile.Br J Anaesth2009https://conductscience.org/library/papers/19474215PubMed
1117,522,627Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.Neuropsychopharmacology2008https://conductscience.org/library/papers/17522627PubMed
1221,481,103Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice.Addict Biol2013https://conductscience.org/library/papers/21481103PubMed
1329,127,295Clinical Potential of an Enzyme-based Novel Therapy for Cocaine Overdose.Sci Rep2017https://conductscience.org/library/papers/29127295PubMed
148,555,282Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.J Addict Dis1995https://conductscience.org/library/papers/8555282PubMed
1517,475,739A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.Am J Psychiatry2007https://conductscience.org/library/papers/17475739PubMed
1631,010,646Hot topics in opioid pharmacology: mixed and biased opioids.Br J Anaesth2019https://conductscience.org/library/papers/31010646PubMed
178,163,014cDNA cloning and regional distribution of a novel member of the opioid receptor family.FEBS Lett1994https://conductscience.org/library/papers/8163014PubMed
1830,531,478Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study.J Clin Psychopharmacol2019https://conductscience.org/library/papers/30531478PubMed
1911,710,090Definition of and mechanism for opioid-induced sedation.Pain Manag Nurs2001https://conductscience.org/library/papers/11710090PubMed
2025,677,778Nociceptin/orphanin-FQ modulation of learning and memory.Vitam Horm2015https://conductscience.org/library/papers/25677778PubMed
2124,680,219Abuse and diversion of buprenorphine sublingual tablets and film.J Subst Abuse Treat2014https://conductscience.org/library/papers/24680219PubMed

See all 71 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42,515,800Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use Disorder.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515800PubMed
41,465,239Effects of Fentanyl-Adulterated Methamphetamine on Circulating Ghrelin in Rats.Int J Mol Sci2025https://conductscience.org/library/papers/41465239PubMed
40,969,879Development of a Ghrelin Deacylase to Attenuate Drug Reward and Associated Effects of Methamphetamine.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40969879PubMed
40,076,960Effects of Fentanyl-Laced Cocaine on Circulating Ghrelin, Insulin, and Glucose Levels in Rats.Int J Mol Sci2025https://conductscience.org/library/papers/40076960PubMed
39,146,775A quantitative LC-MS/MS method for investigation of polysubstance use involving heroin and cocaine.J Pharm Biomed Anal2024https://conductscience.org/library/papers/39146775PubMed
38,740,850In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase.Sci Rep2024https://conductscience.org/library/papers/38740850PubMed
38,256,863Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38256863PubMed
38,195,724Long-lasting blocking of interoceptive effects of cocaine by a highly efficient cocaine hydrolase in rats.Sci Rep2024https://conductscience.org/library/papers/38195724PubMed
36,635,293Catalytic activities of a highly efficient cocaine hydrolase for hydrolysis of biologically active cocaine metabolites norcocaine and benzoylecgonine.Sci Rep2023https://conductscience.org/library/papers/36635293PubMed
32,710,979Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.Neuropharmacology2020https://conductscience.org/library/papers/32710979PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
OPRK14,986PubTator's text mininghttps://conductscience.org/library/genes/4986NCBI Gene
OPRL14,987PubTator's text mininghttps://conductscience.org/library/genes/4987NCBI Gene
OPRM14,988PubTator's text mininghttps://conductscience.org/library/genes/4988NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32389751

GET https://conductscience.org/api/papers/v1/32389751/references?page=2